Pluri (PLUR) Cash & Current Investments (2010 - 2025)
Pluri (PLUR) reported Cash & Current Investments of $4.9 million for Q4 2025, down 34.39% year-over-year from $7.5 million in Q4 2024, and down 67.36% quarter-over-quarter from $15.1 million in Q3 2025.
Pluri (PLUR) Cash & Current Investments (2010 - 2025) Analysis & Trends
Pluri (PLUR) has 16 years of Cash & Current Investments data on file, last reported at $4.9 million in Q4 2025.
- Cash & Current Investments for Q4 2025 came in at $4.9 million, down 34.39% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.9 million (down 34.39% YoY), and the FY2025 annual result was $20.6 million, down 31.26% from the prior year.
- Cash & Current Investments fell to $4.9 million in Q4 2025 per PLUR's latest filing, from $15.1 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $109.0 million in Q1 2021 and troughed at $3.6 million in Q3 2024.
- A 5-year average of $29.6 million and a median of $20.2 million in 2021 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2021 and 2023: Cash & Current Investments surged 1149.55% in 2021, then plunged 88.75% in 2023.
- A 5-year view of Cash & Current Investments shows it stood at $19.7 million in 2021, then jumped by 146.32% to $48.6 million in 2022, then tumbled by 85.89% to $6.9 million in 2023, then grew by 9.2% to $7.5 million in 2024, then plunged by 34.39% to $4.9 million in 2025.
- Business Quant data shows PLUR's Cash & Current Investments at $4.9 million in Q4 2025, $15.1 million in Q3 2025, and $20.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 2.13 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 2.77 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 18.44 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 7.20 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 7.25 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Pluri | 21.85 Mn | 22.34 Mn | 86,000.00 | 4.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.91 Mn |
| Sep 30, 2025 | 15.06 Mn |
| Jun 30, 2025 | 20.61 Mn |
| Mar 31, 2025 | 8.91 Mn |
| Dec 31, 2024 | 7.49 Mn |
| Sep 30, 2024 | 3.56 Mn |
| Jun 30, 2024 | 29.99 Mn |
| Mar 31, 2024 | 8.26 Mn |
| Dec 31, 2023 | 6.86 Mn |
| Sep 30, 2023 | 5.55 Mn |
| Jun 30, 2023 | 41.07 Mn |
| Mar 31, 2023 | 4.86 Mn |
| Dec 31, 2022 | 48.60 Mn |
| Sep 30, 2022 | 49.30 Mn |
| Jun 30, 2022 | 56.66 Mn |
| Mar 31, 2022 | 25.40 Mn |
| Dec 31, 2021 | 19.73 Mn |
| Sep 30, 2021 | 61.28 Mn |
| Jun 30, 2021 | 65.55 Mn |
| Mar 31, 2021 | 109.00 Mn |